01 6Doptelet
Main Therapeutic Indication : Hematology
Currency : USD
2019 Revenue in Millions : 3
2018 Revenue in Millions : 0
Growth (%) : New launch
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 70
2019 Revenue in Millions : 4
Growth (%) : 1,626
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 120
2020 Revenue in Millions : 65
Growth (%) : 90
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 238
2021 Revenue in Millions : 120
Growth (%) : 98
Main Therapeutic Indication : Hematology
Currency : USD
2023 Revenue in Millions : 288
2022 Revenue in Millions : 238
Growth (%) : 19
Main Therapeutic Indication : Hematology
Currency : USD
2024 Revenue in Millions : 386
2023 Revenue in Millions : 288
Growth (%) : 34
